Article: SUBLINGUAL IMMUNOTHERAPY HELPS GRASS-POLLEN ALLERGY SUFFERERS REDUCE MEDICATIONS.

A French medical research team conducted a multicenter controlled study of 136 adults (mean age, 27 years) who suffer from grass-pollen allergies (as confirmed through testing and clinical history). The investigators tested the effectiveness of sublingual immunotherapy, using a standardized grass-pollen extract, in diminishing the patients' rhinoconjunctivitis. In sublingual immunotherapy (SLIT), the patient holds the extract under the tongue (for a prescribed period) and then swallows it. It is an alternative to subcutaneous injection.

In this double-blind randomized study, the researchers compared reaction of the control group, who received a placebo, with that ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!